查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1859051

抗碳青黴烯類腸桿菌科細菌檢測市場報告：至2031年的趨勢、預測及競爭分析

Carbapenem-Resistant Enterobacteriaceae Testing Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

受醫院和診所市場機會的推動，全球抗碳青黴烯類腸桿菌檢測市場前景廣闊。預計2025年至2031年，該市場將以9.9%的年複合成長率成長。推動該市場成長的關鍵因素包括衣原體感染疾病發病率的上升、診斷技術的不斷進步以及監管機構對感染控制日益重視。

  • Lucintel 預測，依類型分類，最低限度的感染控制措施預計將在預測期內實現高速成長。
  • 依用途分類，預計醫院將高速成長。
  • 從區域來看，預計亞太地區在預測期內將達到最高成長。

抗碳青黴烯類腸桿菌科細菌檢測市場的新趨勢

受抗菌素抗藥性帶來的全球健康威脅的迫切影響，抗碳青黴烯類腸桿菌科細菌檢測市場正經歷快速變革。這些新興趨勢著重於提升診斷能力、簡化工作流程，並提高抗碳青黴烯類腸桿菌科細菌檢測的速度和可及性，以有效遏制其傳播。

  • 快速分子診斷：目前快速分子診斷平台的發展趨勢是能夠在數小時而非數天內檢測出抗碳青黴烯類基因，能夠快速識別抗碳青黴烯類腸桿菌科細菌，進而快速實施感染控制措施並及時給予適當的抗生素，直接影響患者的治療結果。
  • 即時檢測：開發適用於照護現場（POC）的抗碳青黴烯類腸桿菌科細菌檢測方案是新興趨勢。 POC 減少了將樣本送到中心實驗室的需求，並有助於在患者床邊或小型診所進行快速診斷。
  • 次世代定序用於監測：NGS 擴大用於對抗碳青黴烯類腸桿菌科分離株進行詳細的基因組表徵，以用於監測目的，能夠精確識別抗藥性機制、追蹤傳播途徑和了解疫情的流行病學，這可以為遏制抗碳青黴烯類腸桿菌科傳播的公共衛生策略提供資訊。
  • 多重檢測：一個重要的趨勢是採用多重檢測技術，可以同時檢測多種碳青黴烯酶基因和其他抗藥性標記。這些檢測方法可在單次檢測中提供全面的資訊，降低檢測的複雜性，提高診斷效率，並有助於制定更明智的治療決策。
  • 自動化和高通量系統：用於檢測抗碳青黴烯類腸桿菌科細菌的自動化和高通量系統在臨床實驗室中越來越普遍。這一趨勢目的是提高檢測能力、減少人為錯誤並提高工作流程效率，使實驗室能夠處理更多檢體並獲得一致可靠的結果。

這些趨勢從根本上重塑了抗碳青黴烯類腸桿菌科細菌檢測市場，推動向更快、更便捷、更全面的診斷解決方案轉變，加快臨床決策，加強感染控制工作，支持強力的監測，並最終為全球對抗抗菌素抗藥性的鬥爭做出重大貢獻。

抗碳青黴烯類腸桿菌科細菌檢測市場的最新趨勢

近年來，受抗生素抗藥性日益嚴重的公共衛生威脅以及對提高診斷能力的迫切需求的推動，抗碳青黴烯類腸桿菌科細菌檢測市場取得了多項重大進展。這些進展目的是提高抗碳青黴烯類腸桿菌科細菌檢測的速度、準確性和可及性。

  • 快速分子檢測的商業化：抗碳青黴烯類腸桿菌科細菌的快速分子診斷檢測的商業化和日益普及是一項關鍵進展。這些檢測可在數小時內直接從臨床檢體中識別特定的碳青黴烯類抗生素基因（例如KPC、NDM、OXA-48），與傳統的基於培養的方法相比，顯著縮短了周轉時間。
  • 新型表現型檢測方法的發展：近年來，碳青黴烯類抗生素去活化法（CIM）和改良的碳青黴烯類抗生素去活化法等新型表現型分析方法相繼問世。這些低成本、易於操作的檢測方法正被臨床實驗室廣泛採用，用於確認碳青黴烯類抗生素的產生並提供可靠的結果。
  • 對即時檢測設備的關注日益增加：開發用於檢測抗碳青黴烯類腸桿菌科細菌的近乎或完全即時檢測設備已成為日益成長的趨勢。儘管對於某些複雜目標而言，該技術仍處於起步階段，但其重點在於提供床邊快速檢測結果，以便立即採取感染控制措施並啟動治療。
  • 與實驗室自動化系統的整合：製造商越來越注重開發能夠與現有實驗室自動化系統無縫整合的抗碳青黴烯類腸桿菌科細菌檢測解決方案，增強高通量能力，減少人工操作，最大限度地降低人為錯誤的風險，並提高整個實驗室的效率和一致性。
  • 加強監測和報告平台：近期進展包括創建更先進的數位平台，用於即時監測和報告抗碳青黴烯類腸桿菌科細菌病例。這些平台幫助公共衛生機構監測抗藥性趨勢、識別疫情叢集，並實施有針對性的干涉措施，以有效遏制抗碳青黴烯類腸桿菌科細菌的傳播。

這些市場趨勢共同影響抗碳青黴烯類腸桿菌科細菌檢測市場，它們能夠實現更快更準確的診斷，促進早期感染控制，提高不同環境下檢測的可及性，簡化實驗室工作流程，並加強公共衛生監測，有助於更有效地應對抗菌素抗藥性問題。

目錄

第1章 執行摘要

第2章 市場概覽

  • 背景和分類
  • 供應鏈

第3章 市場趨勢與預測分析

  • 產業促進因素與挑戰
  • PESTLE分析
  • 專利分析
  • 法規環境

第4章 全球抗碳青黴烯類腸桿菌科細菌檢測市場（依類型）

  • 概述
  • 吸引力分析：依類型
  • 改良Hodge：趨勢與預測（2019-2031）
  • 最低限度的感染抑制：趨勢與預測（2019-2031年）

第5章 全球抗碳青黴烯類腸桿菌科細菌檢測市場（依應用）

  • 概述
  • 吸引力分析：依應用
  • 醫院：趨勢與預測（2019-2031）
  • 診所：趨勢與預測（2019-2031年）
  • 其他：趨勢與預測（2019-2031年）

第6章 區域分析

  • 概述
  • 全球抗碳青黴烯類腸桿菌科細菌檢測市場（依地區）

第7章 北美抗碳青黴烯類腸桿菌科細菌檢測市場

  • 概述
  • 北美抗碳青黴烯類腸桿菌科細菌檢測市場（依類型）
  • 北美抗碳青黴烯類腸桿菌科細菌檢測市場（依應用）
  • 美國抗碳青黴烯類腸桿菌科細菌檢測市場
  • 墨西哥抗碳青黴烯類腸桿菌科細菌檢測市場
  • 加拿大抗碳青黴烯類腸桿菌科細菌檢測市場

第8章 歐洲抗碳青黴烯類腸桿菌檢測市場

  • 概述
  • 歐洲抗碳青黴烯類腸桿菌科細菌檢測市場（依類型）
  • 歐洲抗碳青黴烯類腸桿菌科細菌檢測市場（依應用）
  • 德國抗碳青黴烯類腸桿菌科細菌檢測市場
  • 法國抗碳青黴烯類腸桿菌科細菌檢測市場
  • 西班牙抗碳青黴烯類腸桿菌科細菌檢測市場
  • 義大利抗碳青黴烯類腸桿菌科細菌檢測市場
  • 英國抗碳青黴烯類腸桿菌科細菌檢測市場

第9章 亞太地區抗碳青黴烯類腸桿菌科細菌檢測市場

  • 概述
  • 亞太地區抗碳青黴烯類腸桿菌科細菌檢測市場（依類型）
  • 亞太地區抗碳青黴烯類腸桿菌科細菌檢測市場（依應用）
  • 日本抗碳青黴烯類腸桿菌科細菌檢測市場
  • 印度抗碳青黴烯類腸桿菌科細菌檢測市場
  • 中國抗碳青黴烯類腸桿菌科細菌檢測市場
  • 韓國抗碳青黴烯類腸桿菌科細菌檢測市場
  • 印尼抗碳青黴烯類腸桿菌科細菌檢測市場

第10章 世界其他地區（ROW）抗碳青黴烯類腸桿菌科細菌檢測市場

  • 概述
  • ROW 抗碳青黴烯類腸桿菌科細菌檢測市場（依類型）
  • ROW 抗碳青黴烯類腸桿菌科細菌檢測市場（依應用）
  • 中東地區抗碳青黴烯類腸桿菌科細菌檢測市場
  • 南美洲抗碳青黴烯類腸桿菌科細菌檢測市場
  • 非洲抗碳青黴烯類腸桿菌科細菌檢測市場

第11章 競爭分析

  • 產品系列分析
  • 運作整合
  • 波特五力分析
    • 競爭敵對
    • 買方議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 新進入者的威脅
  • 市場佔有率分析

第12章 機會與策略分析

  • 價值鏈分析
  • 成長機會分析
    • 成長機會：依類型
    • 成長機會：依應用
  • 全球抗碳青黴烯類腸桿菌科細菌檢測市場新興趨勢
  • 戰略分析
    • 新產品開發
    • 認證和許可
    • 企業合併、協議、合作關係和合資企業

第13章 價值鏈中主要企業的概況

  • 競爭分析
  • TBA
  • SolGent
  • ELITechGroup
  • ALIFAX
  • BioMerieux

第14章 附錄

  • 圖表清單
  • 表格列表
  • 分析方法
  • 免責聲明
  • 版權
  • 簡稱和技術單位
  • 關於 Lucintel
  • 詢問

The future of the global carbapenem-resistant enterobacteriaceae testing market looks promising with opportunities in the hospital and clinic markets. The global carbapenem-resistant enterobacteriaceae testing market is expected to grow with a CAGR of 9.9% from 2025 to 2031. The major drivers for this market are the increasing incidence of cre infections, the rising advancements in diagnostic technologies, and the growing regulatory emphasis on infection control.

  • Lucintel forecasts that, within the type category, minimal inhibitory is expected to witness higher growth over the forecast period.
  • Within the application category, hospital is expected to witness higher growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Carbapenem-Resistant Enterobacteriaceae Testing Market

The carbapenem-resistant enterobacteriaceae testing market is undergoing dynamic changes, largely driven by the urgent global health threat posed by antimicrobial resistance. These emerging trends are focused on enhancing diagnostic capabilities, streamlining workflows, and improving the speed and accessibility of carbapenem-resistant enterobacteriaceae detection to combat its spread effectively.

  • Rapid Molecular Diagnostics: There's a strong trend towards rapid molecular diagnostic platforms capable of detecting carbapenems genes within hours, rather than days. This allows for quicker identification of carbapenem-resistant enterobacteriaceae, enabling faster implementation of infection control measures and timely administration of appropriate antibiotics, directly impacting patient outcomes.
  • Point-of-Care Testing: The development of carbapenem-resistant enterobacteriaceae testing solutions suitable for point-of-care settings is an emerging trend. POCT reduces the need for sending samples to centralized laboratories, facilitating quicker diagnosis at the patient's bedside or in smaller clinics, which is crucial for early intervention and preventing further transmission in various healthcare settings.
  • Next-Generation Sequencing for Surveillance: NGS is increasingly being utilized for detailed genomic characterization of carbapenem-resistant enterobacteriaceae isolates for surveillance purposes. This allows for precise identification of resistance mechanisms, tracking transmission routes, and understanding the epidemiology of outbreaks, informing public health strategies to contain the spread of carbapenem-resistant enterobacteriaceae.
  • Multiplex Assays: The adoption of multiplex assays capable of simultaneously detecting multiple carbapenemase genes and other resistance markers is a key trend. These assays offer comprehensive information from a single test, reducing testing complexity, improving diagnostic efficiency, and enabling more informed treatment decisions.
  • Automation and High-Throughput Systems: Automation and high-throughput systems are becoming more prevalent in clinical laboratories for carbapenem-resistant enterobacteriaceae testing. This trend aims to increase testing capacity, reduce manual errors, and improve workflow efficiency, allowing laboratories to process a larger volume of samples with consistent and reliable results.

These trends are fundamentally reshaping the carbapenem-resistant enterobacteriaceae testing market by driving towards faster, more accessible, and comprehensive diagnostic solutions. They enable quicker clinical decisions, enhance infection control efforts, support robust surveillance, and ultimately contribute significantly to the global fight against antimicrobial resistance.

Recent Developments in the Carbapenem-Resistant Enterobacteriaceae Testing Market

The carbapenem-resistant enterobacteriaceae testing market has recently witnessed several crucial developments, driven by the escalating public health threat of antibiotic resistance and the urgent need for improved diagnostic capabilities. These advancements are aimed at enhancing the speed, accuracy, and accessibility of carbapenem-resistant enterobacteriaceae detection.

  • Commercialization of Rapid Molecular Tests: A significant development is the commercialization and increased adoption of rapid molecular diagnostic tests for carbapenem-resistant enterobacteriaceae. These tests can identify specific carbapenems genes (e.g., KPC, NDM, OXA-48) directly from clinical samples in a few hours, drastically reducing turnaround time compared to traditional culture-based methods.
  • Development of Novel Phenotypic Assays: Recent years have seen the introduction of new phenotypic assays, such as carbapenem inactivation methods (CIM) and modified carbapenem inactivation methods. These low-cost, easy-to-perform tests are becoming more widely adopted for confirming carbapenems production in clinical laboratories, offering reliable results.
  • Increased Focus on Point-of-Care Devices: There's a growing trend in the development of near point-of-care or even true point-of-care devices for carbapenem-resistant enterobacteriaceae detection. While still in early stages for some complex targets, efforts are focused on providing rapid results at the bedside, enabling immediate infection control measures and treatment initiation.
  • Integration with Laboratory Automation Systems: Manufacturers are increasingly focusing on developing carbapenem-resistant enterobacteriaceae testing solutions that seamlessly integrate with existing laboratory automation systems. This enhances high-throughput capabilities, reduces manual labor, and minimizes the risk of human error, improving overall laboratory efficiency and consistency.
  • Enhanced Surveillance and Reporting Platforms: Recent developments include the creation of more sophisticated digital platforms for real-time surveillance and reporting of carbapenem-resistant enterobacteriaceae cases. These platforms aid public health agencies in monitoring resistance trends, identifying outbreak clusters, and implementing targeted interventions to control the spread of carbapenem-resistant enterobacteriaceae effectively.

These developments are collectively impacting the carbapenem-resistant enterobacteriaceae testing market by enabling faster and more accurate diagnosis, facilitating earlier infection control, improving accessibility of testing in diverse settings, streamlining laboratory workflows, and strengthening public health surveillance, all contributing to a more effective response against antimicrobial resistance.

Strategic Growth Opportunities in the Carbapenem-Resistant Enterobacteriaceae Testing Market

The carbapenem-resistant enterobacteriaceae testing market offers significant strategic growth opportunities across various key applications, driven by the escalating global burden of antimicrobial resistance and the critical need for rapid, accurate diagnostics. Capitalizing on these application-specific demands will be vital for market players.

  • Hospital and Clinical Diagnostics: The primary growth opportunity lies in equipping hospitals and clinical laboratories with advanced carbapenem-resistant enterobacteriaceae testing solutions. Rapid and accurate identification is crucial for timely patient management, preventing healthcare-associated infections, and implementing effective isolation protocols to contain outbreaks within healthcare facilities.
  • Infection Control and Surveillance Programs: Governments and healthcare organizations are investing heavily in national and regional infection control and surveillance programs. This presents a major growth opportunity for carbapenem-resistant enterobacteriaceae testing, as diagnostics are fundamental for monitoring resistance trends, identifying high-risk areas, and guiding public health interventions.
  • Pharmaceutical and Biotech R&D: The development of new antibiotics and therapeutic strategies against carbapenem-resistant enterobacteriaceae requires extensive testing during preclinical and clinical trials. This creates a niche but significant growth opportunity for specialized carbapenem-resistant enterobacteriaceae testing services and kits that can accurately assess the efficacy of novel antimicrobial compounds.
  • Veterinary Diagnostics: While human health is the primary focus, the "One Health" approach recognizes the link between human and animal health. Growing awareness of antimicrobial resistance in livestock and companion animals presents an emerging opportunity for carbapenem-resistant enterobacteriaceae testing in veterinary diagnostics to monitor and control resistance spread.
  • Point-of-Care and Decentralized Testing: The push for decentralized healthcare and rapid decision-making creates opportunities for compact, easy-to-use carbapenem-resistant enterobacteriaceae testing devices suitable for smaller clinics, emergency rooms, or even remote settings. This expands accessibility and reduces turnaround times, crucial for immediate patient management and infection control.

These strategic growth opportunities are profoundly impacting the carbapenem-resistant enterobacteriaceae testing market by driving the development of specialized and versatile diagnostic solutions tailored to the unique needs of each application. This leads to increased innovation, diversified product portfolios, and expanded market reach, ultimately strengthening the global response to antimicrobial resistance.

Carbapenem-Resistant Enterobacteriaceae Testing Market Driver and Challenges

The carbapenem-resistant enterobacteriaceae testing market's trajectory is shaped by a complex interplay of various technological, economic, and regulatory factors. Major drivers stem from the urgent global health threat of antimicrobial resistance, while challenges include high testing costs, the technical complexity of emerging methods, and stringent regulatory pathways.

The factors responsible for driving the carbapenem-resistant enterobacteriaceae testing market include:

1. Rising Global Incidence of carbapenem-resistant enterobacteriaceae Infections: The escalating prevalence of carbapenem-resistant enterobacteriaceae infections worldwide is the most significant driver. These "superbugs" cause severe, often untreatable infections, leading to higher morbidity and mortality rates, thereby creating an urgent and growing demand for rapid and accurate diagnostic tools to combat their spread.

2. Increasing Awareness and Surveillance Initiatives: Greater awareness among healthcare professionals and the public about the dangers of carbapenem-resistant enterobacteriaceae, coupled with increased national and international surveillance programs, is driving market growth. These initiatives emphasize early detection and reporting, boosting the demand for effective testing solutions to monitor and control resistance.

3. Technological Advancements in Diagnostics: Continuous innovation in diagnostic technologies, particularly in molecular assays (PCR, NGS) and automated phenotypic methods, is a key driver. These advancements offer improved sensitivity, specificity, and faster turnaround times, enabling more precise and timely identification of carbapenem-resistant enterobacteriaceae, which directly impacts treatment decisions.

4. Growing Healthcare Expenditure: Increased healthcare spending, particularly in developing nations, contributes to market expansion. As healthcare infrastructure improves and access to advanced diagnostics becomes more widespread, there's a greater capacity and willingness to invest in carbapenem-resistant enterobacteriaceae testing technologies to improve patient outcomes and infection control.

5. Antimicrobial Stewardship Programs: The global push for antimicrobial stewardship programs aims to optimize antibiotic use and curb resistance. carbapenem-resistant enterobacteriaceae testing plays a critical role by guiding appropriate antibiotic selection, preventing empirical broad-spectrum treatment, and supporting infection control measures, thereby fostering responsible antibiotic use.

Challenges in the carbapenem-resistant enterobacteriaceae testing market are:

1. High Cost of Advanced Technologies: The significant upfront cost of advanced molecular diagnostic platforms and reagents can be a major challenge, especially for healthcare facilities in resource-limited settings. This high investment can limit widespread adoption, despite the clinical benefits of rapid and accurate carbapenem-resistant enterobacteriaceae detection.

2. Technical Complexity and Skilled Personnel: Many advanced carbapenem-resistant enterobacteriaceae testing methods, particularly molecular and genomic techniques, require specialized equipment, complex protocols, and highly trained laboratory personnel for accurate execution and interpretation. A shortage of skilled staff can hinder the effective implementation and widespread use of these diagnostics.

3. Regulatory and Reimbursement Hurdles: The development and commercialization of new carbapenem-resistant enterobacteriaceae diagnostic tests face stringent regulatory approval processes, which can be time-consuming and costly. Additionally, securing adequate reimbursement from healthcare payers for these tests can be a challenge, impacting their market penetration and accessibility.

These drivers and challenges on the carbapenem-resistant enterobacteriaceae testing market is a dynamic push for more rapid, accurate, and accessible diagnostics to combat the escalating threat of antimicrobial resistance. However, overcoming the hurdles of cost, technical complexity, and regulatory pathways remains critical for achieving widespread adoption and maximizing the public health benefit of these essential tests.

List of Carbapenem-Resistant Enterobacteriaceae Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies carbapenem-resistant enterobacteriaceae testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the carbapenem-resistant enterobacteriaceae testing companies profiled in this report include-

  • TBA
  • SolGent
  • ELITechGroup
  • ALIFAX
  • BioMerieux

Carbapenem-Resistant Enterobacteriaceae Testing Market by Segment

The study includes a forecast for the global carbapenem-resistant enterobacteriaceae testing market by type, application, and region.

Carbapenem-Resistant Enterobacteriaceae Testing Market by Type [Value from 2019 to 2031]:

  • Modified Hodge
  • Minimal Inhibitory

Carbapenem-Resistant Enterobacteriaceae Testing Market by Application [Value from 2019 to 2031]:

  • Hospitals
  • Clinics
  • Others

Carbapenem-Resistant Enterobacteriaceae Testing Market by Region [Value from 2019 to 2031]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Carbapenem-Resistant Enterobacteriaceae Testing Market

The carbapenem-resistant enterobacteriaceae testing market is experiencing robust growth driven by the escalating global prevalence of these highly resistant "nightmare bacteria" and the urgent need for rapid, accurate diagnostics. Recent developments focus on improving detection speed, specificity, and accessibility of testing, crucial for timely treatment and effective infection control. This evolution is underpinned by a global commitment to combating antimicrobial resistance and enhancing public health surveillance.

  • United States: The US market is characterized by a strong emphasis on rapid molecular diagnostics and advanced automated systems for carbapenem-resistant enterobacteriaceae detection, driven by the CDC's focus on antimicrobial resistance. Significant investment in R&D aims to provide faster turnaround times for results, crucial for managing outbreaks and guiding appropriate treatment in healthcare settings.
  • China: China carbapenem-resistant enterobacteriaceae testing market is rapidly expanding due to increasing awareness, growing healthcare expenditure, and a rising incidence of antibiotic-resistant infections. There's a dual focus on developing indigenous diagnostic solutions and adopting international technologies to strengthen its capacity for rapid and accurate carbapenem-resistant enterobacteriaceae identification.
  • Germany: Germany market for carbapenem-resistant enterobacteriaceae testing prioritizes high-quality, reliable diagnostic platforms, integrating seamlessly with its advanced healthcare infrastructure. Developments include sophisticated molecular assays and phenotypic tests, supporting comprehensive antimicrobial stewardship programs and robust surveillance efforts to control resistance.
  • India: India carbapenem-resistant enterobacteriaceae testing market is witnessing significant growth, spurred by a large patient population, improving healthcare facilities, and a growing burden of antibiotic resistance. There's an increasing demand for cost-effective and rapid diagnostic solutions, including both conventional and molecular methods, to address the challenge of carbapenem-resistant enterobacteriaceae in diverse clinical settings.
  • Japan: Japan carbapenem-resistant enterobacteriaceae testing market emphasizes precision and technological innovation, with a focus on advanced molecular diagnostics for rapid identification of carbapenems genes. Developments are geared towards highly sensitive and specific tests to support strict infection control measures and facilitate prompt, targeted treatment strategies in its healthcare system.

Features of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market

  • Market Size Estimates: Carbapenem-resistant enterobacteriaceae testing market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Carbapenem-resistant enterobacteriaceae testing market size by type, application, and region in terms of value ($B).
  • Regional Analysis: Carbapenem-resistant enterobacteriaceae testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different type, applications, and regions for the carbapenem-resistant enterobacteriaceae testing market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the carbapenem-resistant enterobacteriaceae testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the carbapenem-resistant enterobacteriaceae testing market by type (modified hodge and minimal inhibitory), application (hospitals, clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Type
  • 4.3 Modified Hodge: Trends and Forecast (2019-2031)
  • 4.4 Minimal Inhibitory: Trends and Forecast (2019-2031)

5. Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Hospitals: Trends and Forecast (2019-2031)
  • 5.4 Clinics: Trends and Forecast (2019-2031)
  • 5.5 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

  • 6.1 Overview
  • 6.2 Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Region

7. North American Carbapenem-Resistant Enterobacteriaceae Testing Market

  • 7.1 Overview
  • 7.2 North American Carbapenem-Resistant Enterobacteriaceae Testing Market by Type
  • 7.3 North American Carbapenem-Resistant Enterobacteriaceae Testing Market by Application
  • 7.4 United States Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 7.5 Mexican Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 7.6 Canadian Carbapenem-Resistant Enterobacteriaceae Testing Market

8. European Carbapenem-Resistant Enterobacteriaceae Testing Market

  • 8.1 Overview
  • 8.2 European Carbapenem-Resistant Enterobacteriaceae Testing Market by Type
  • 8.3 European Carbapenem-Resistant Enterobacteriaceae Testing Market by Application
  • 8.4 German Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 8.5 French Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 8.6 Spanish Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 8.7 Italian Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 8.8 United Kingdom Carbapenem-Resistant Enterobacteriaceae Testing Market

9. APAC Carbapenem-Resistant Enterobacteriaceae Testing Market

  • 9.1 Overview
  • 9.2 APAC Carbapenem-Resistant Enterobacteriaceae Testing Market by Type
  • 9.3 APAC Carbapenem-Resistant Enterobacteriaceae Testing Market by Application
  • 9.4 Japanese Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 9.5 Indian Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 9.6 Chinese Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 9.7 South Korean Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 9.8 Indonesian Carbapenem-Resistant Enterobacteriaceae Testing Market

10. ROW Carbapenem-Resistant Enterobacteriaceae Testing Market

  • 10.1 Overview
  • 10.2 ROW Carbapenem-Resistant Enterobacteriaceae Testing Market by Type
  • 10.3 ROW Carbapenem-Resistant Enterobacteriaceae Testing Market by Application
  • 10.4 Middle Eastern Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 10.5 South American Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 10.6 African Carbapenem-Resistant Enterobacteriaceae Testing Market

11. Competitor Analysis

  • 11.1 Product Portfolio Analysis
  • 11.2 Operational Integration
  • 11.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

  • 12.1 Value Chain Analysis
  • 12.2 Growth Opportunity Analysis
    • 12.2.1 Growth Opportunities by Type
    • 12.2.2 Growth Opportunities by Application
  • 12.3 Emerging Trends in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market
  • 12.4 Strategic Analysis
    • 12.4.1 New Product Development
    • 12.4.2 Certification and Licensing
    • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

  • 13.1 Competitive Analysis
  • 13.2 TBA
    • Company Overview
    • Carbapenem-Resistant Enterobacteriaceae Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.3 SolGent
    • Company Overview
    • Carbapenem-Resistant Enterobacteriaceae Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.4 ELITechGroup
    • Company Overview
    • Carbapenem-Resistant Enterobacteriaceae Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.5 ALIFAX
    • Company Overview
    • Carbapenem-Resistant Enterobacteriaceae Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 13.6 BioMerieux
    • Company Overview
    • Carbapenem-Resistant Enterobacteriaceae Testing Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

14. Appendix

  • 14.1 List of Figures
  • 14.2 List of Tables
  • 14.3 Research Methodology
  • 14.4 Disclaimer
  • 14.5 Copyright
  • 14.6 Abbreviations and Technical Units
  • 14.7 About Us
  • 14.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market
  • Figure 2.1: Usage of Carbapenem-Resistant Enterobacteriaceae Testing Market
  • Figure 2.2: Classification of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market
  • Figure 2.3: Supply Chain of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market
  • Figure 3.1: Driver and Challenges of the Carbapenem-Resistant Enterobacteriaceae Testing Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type
  • Figure 4.3: Forecast for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type
  • Figure 4.4: Trends and Forecast for Modified Hodge in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Minimal Inhibitory in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Figure 5.1: Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application
  • Figure 5.3: Forecast for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Hospitals in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Clinics in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Figure 5.6: Trends and Forecast for Others in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Figure 6.1: Trends of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Region (2019-2024)
  • Figure 6.2: Forecast for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Region (2025-2031)
  • Figure 7.1: North American Carbapenem-Resistant Enterobacteriaceae Testing Market by Type in 2019, 2024, and 2031
  • Figure 7.2: Trends of the North American Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2019-2024)
  • Figure 7.3: Forecast for the North American Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2025-2031)
  • Figure 7.4: North American Carbapenem-Resistant Enterobacteriaceae Testing Market by Application in 2019, 2024, and 2031
  • Figure 7.5: Trends of the North American Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2019-2024)
  • Figure 7.6: Forecast for the North American Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2025-2031)
  • Figure 7.7: Trends and Forecast for the United States Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 7.8: Trends and Forecast for the Mexican Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 7.9: Trends and Forecast for the Canadian Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 8.1: European Carbapenem-Resistant Enterobacteriaceae Testing Market by Type in 2019, 2024, and 2031
  • Figure 8.2: Trends of the European Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2019-2024)
  • Figure 8.3: Forecast for the European Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2025-2031)
  • Figure 8.4: European Carbapenem-Resistant Enterobacteriaceae Testing Market by Application in 2019, 2024, and 2031
  • Figure 8.5: Trends of the European Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2019-2024)
  • Figure 8.6: Forecast for the European Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2025-2031)
  • Figure 8.7: Trends and Forecast for the German Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 8.8: Trends and Forecast for the French Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the Spanish Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 8.10: Trends and Forecast for the Italian Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 8.11: Trends and Forecast for the United Kingdom Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 9.1: APAC Carbapenem-Resistant Enterobacteriaceae Testing Market by Type in 2019, 2024, and 2031
  • Figure 9.2: Trends of the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2019-2024)
  • Figure 9.3: Forecast for the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2025-2031)
  • Figure 9.4: APAC Carbapenem-Resistant Enterobacteriaceae Testing Market by Application in 2019, 2024, and 2031
  • Figure 9.5: Trends of the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2019-2024)
  • Figure 9.6: Forecast for the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2025-2031)
  • Figure 9.7: Trends and Forecast for the Japanese Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 9.8: Trends and Forecast for the Indian Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Chinese Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the South Korean Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the Indonesian Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 10.1: ROW Carbapenem-Resistant Enterobacteriaceae Testing Market by Type in 2019, 2024, and 2031
  • Figure 10.2: Trends of the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2019-2024)
  • Figure 10.3: Forecast for the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Type (2025-2031)
  • Figure 10.4: ROW Carbapenem-Resistant Enterobacteriaceae Testing Market by Application in 2019, 2024, and 2031
  • Figure 10.5: Trends of the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2019-2024)
  • Figure 10.6: Forecast for the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) by Application (2025-2031)
  • Figure 10.7: Trends and Forecast for the Middle Eastern Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 10.8: Trends and Forecast for the South American Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the African Carbapenem-Resistant Enterobacteriaceae Testing Market ($B) (2019-2031)
  • Figure 11.1: Porter's Five Forces Analysis of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market
  • Figure 11.2: Market Share (%) of Top Players in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2024)
  • Figure 12.1: Growth Opportunities for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Type
  • Figure 12.2: Growth Opportunities for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Application
  • Figure 12.3: Growth Opportunities for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Region
  • Figure 12.4: Emerging Trends in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Carbapenem-Resistant Enterobacteriaceae Testing Market by Type and Application
  • Table 1.2: Attractiveness Analysis for the Carbapenem-Resistant Enterobacteriaceae Testing Market by Region
  • Table 1.3: Global Carbapenem-Resistant Enterobacteriaceae Testing Market Parameters and Attributes
  • Table 3.1: Trends of the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 3.2: Forecast for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Type
  • Table 4.2: Market Size and CAGR of Various Type in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Type in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 4.4: Trends of Modified Hodge in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 4.5: Forecast for Modified Hodge in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 4.6: Trends of Minimal Inhibitory in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 4.7: Forecast for Minimal Inhibitory in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Carbapenem-Resistant Enterobacteriaceae Testing Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 5.4: Trends of Hospitals in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 5.5: Forecast for Hospitals in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 5.6: Trends of Clinics in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 5.7: Forecast for Clinics in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 5.8: Trends of Others in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 5.9: Forecast for Others in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 6.1: Market Size and CAGR of Various Regions in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 6.2: Market Size and CAGR of Various Regions in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 7.1: Trends of the North American Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 7.2: Forecast for the North American Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 7.3: Market Size and CAGR of Various Type in the North American Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 7.4: Market Size and CAGR of Various Type in the North American Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 7.5: Market Size and CAGR of Various Application in the North American Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 7.6: Market Size and CAGR of Various Application in the North American Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 7.7: Trends and Forecast for the United States Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 7.8: Trends and Forecast for the Mexican Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 7.9: Trends and Forecast for the Canadian Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 8.1: Trends of the European Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 8.2: Forecast for the European Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Type in the European Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Type in the European Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various Application in the European Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various Application in the European Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 8.7: Trends and Forecast for the German Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 8.8: Trends and Forecast for the French Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Spanish Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 8.10: Trends and Forecast for the Italian Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 8.11: Trends and Forecast for the United Kingdom Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 9.1: Trends of the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 9.2: Forecast for the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Type in the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Type in the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various Application in the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various Application in the APAC Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 9.7: Trends and Forecast for the Japanese Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 9.8: Trends and Forecast for the Indian Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Chinese Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 9.10: Trends and Forecast for the South Korean Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 9.11: Trends and Forecast for the Indonesian Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 10.1: Trends of the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 10.2: Forecast for the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Type in the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Type in the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various Application in the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various Application in the ROW Carbapenem-Resistant Enterobacteriaceae Testing Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Middle Eastern Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 10.8: Trends and Forecast for the South American Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 10.9: Trends and Forecast for the African Carbapenem-Resistant Enterobacteriaceae Testing Market (2019-2031)
  • Table 11.1: Product Mapping of Carbapenem-Resistant Enterobacteriaceae Testing Suppliers Based on Segments
  • Table 11.2: Operational Integration of Carbapenem-Resistant Enterobacteriaceae Testing Manufacturers
  • Table 11.3: Rankings of Suppliers Based on Carbapenem-Resistant Enterobacteriaceae Testing Revenue
  • Table 12.1: New Product Launches by Major Carbapenem-Resistant Enterobacteriaceae Testing Producers (2019-2024)
  • Table 12.2: Certification Acquired by Major Competitor in the Global Carbapenem-Resistant Enterobacteriaceae Testing Market